Pancreatic Cancer

Memorial Sloan Kettering’s pancreatic cancer team, which is composed of national leaders in the field, is dedicated to providing the highest-quality diagnostic evaluation, treatment, and palliative care for patients with this disease. Our patients also have access to innovative therapies through our clinical trials.

Making an Appointment

Call 800-525-2225
Mon–Fri, 8:30 AM–5:30 PM, ET

Watch a video|For referring physicians

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday possible today.

Guy's Story

When 50-year-old Robert “Guy” Davidson received a diagnosis of pancreatic cancer at another hospital, he came to Memorial Sloan Kettering for a second opinion and stayed for chemotherapy, surgery, and radiation.

Pictured: Robert Kurtz
Pancreatic Tumor Registry

Doctors at Memorial Sloan Kettering are working to identify risk factors that may be related to the development of pancreatic cancer.

Pictured: Steven Leach
David M. Rubenstein Center for Pancreatic Cancer Research

Memorial Sloan Kettering's David M. Rubenstein Center for Pancreatic Cancer Research brings together a multidisciplinary team of scientists dedicated to improving the lives of patients with pancreatic malignancies.

Pictured: William Jarnagin
About Pancreatic Cancer

Memorial Sloan Kettering experts share statistics and facts about pancreatic cancer, including known risk factors for the disease.

Pictured: Mark Schattner
Screening for and Diagnosing Pancreatic Cancer

Experts from Memorial Sloan-Kettering discuss the challenges of screening for pancreatic cancer and improvements in diagnosis.

Pictured: William Jarnagin
New Approaches to Surgery for Pancreatic Cancer

Medical expert William Jarnagin of Memorial Sloan Kettering describes techniques to improve the effectiveness of pancreatic cancer surgery.

Pictured: William Jarnagin
Pancreatic Cancer
Pictured: Mark Schattner
Screening & Diagnosing
Pictured: William Jarnagin
New Approaches